Cui Penglei, Pan Panpan, Qin Ling, Wang Xinluan, Chen Xiaodong, Deng Yonghui, Zhang Xiaoling
Department of Orthopedic Surgery, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, People's Republic of China.
Department of Spine Surgery, Beijing Jishuitan Hospital, Peking University Fourth School of Clinical Medicine, Beijing, 100035, People's Republic of China.
Bioact Mater. 2022 May 4;19:487-498. doi: 10.1016/j.bioactmat.2022.03.032. eCollection 2023 Jan.
The regeneration of articular cartilage remains a great challenge due to the difficulty in effectively enhancing spontaneous healing. Recently, the combination of implanted stem cells, suitable biomaterials and bioactive molecules has attracted attention for tissue regeneration. In this study, a novel injectable nanocomposite was rationally designed as a sustained release platform for enhanced cartilage regeneration through integration of a chitosan-based hydrogel, articular cartilage stem cells (ACSCs) and mesoporous SiO nanoparticles loaded with anhydroicaritin (AHI). The biocompatible engineered nanocomposite acting as a novel 3D biomimetic extracellular matrix exhibited a remarkable sustained release effect due to the synergistic regulation of the organic hydrogel framework and mesopore channels of inorganic mSiO nanoparticles (mSiO NPs). Histological assessment and biomechanical tests showed that the nanocomposites exhibited superior performance in inducing ACSCs proliferation and differentiation and promoting extracellular matrix (ECM) production and cartilage regeneration Such a novel multifunctional biocompatible platform was demonstrated to significantly enhance cartilage regeneration based on the sustained release of AHI, an efficient bioactive natural small molecule for ACSCs chondrogenesis, within the hybrid matrix of hydrogel and mSiO NPs. Hence, the injectable nanocomposite holds great promise for use as a 3D biomimetic extracellular matrix for tissue regeneration in clinical diagnostics.
由于难以有效促进自发愈合,关节软骨的再生仍然是一个巨大的挑战。最近,植入的干细胞、合适的生物材料和生物活性分子的组合在组织再生方面引起了关注。在本研究中,通过整合壳聚糖基水凝胶、关节软骨干细胞(ACSCs)和负载脱水淫羊藿素(AHI)的介孔SiO纳米颗粒,合理设计了一种新型可注射纳米复合材料,作为增强软骨再生的缓释平台。由于有机水凝胶框架和无机介孔SiO纳米颗粒(mSiO NPs)的中孔通道的协同调节,这种具有生物相容性的工程纳米复合材料作为一种新型的三维仿生细胞外基质表现出显著的缓释效果。组织学评估和生物力学测试表明,该纳米复合材料在诱导ACSCs增殖和分化、促进细胞外基质(ECM)产生以及软骨再生方面表现出优异的性能。基于AHI(一种对ACSCs软骨生成有效的生物活性天然小分子)在水凝胶和mSiO NPs的混合基质中的持续释放,这种新型多功能生物相容性平台被证明能显著增强软骨再生。因此,这种可注射纳米复合材料在临床诊断中作为用于组织再生的三维仿生细胞外基质具有很大的应用前景。